Showing results (291-300 of 2,462) with videos related to

Sort By:
Pageof 247
Cancer Treatment Reviews|February 10, 2019
Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE eraMarcello Tucci, Orazio Caffo, Consuelo Buttigliero, et al.
Cancer Treatment Reviews|July 8, 2021
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysisCaroline Boman, Ioannis Zerdes, Kira Mårtensson, et al.
Cancer Treatment Reviews|July 9, 2021
De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysisMarie-France Savard, Mark Clemons, Brian Hutton, et al.
Cancer Treatment Reviews|December 11, 2020
Treatments after first progression in metastatic colorectal cancer. A literature review and evidence-based algorithmCarlotta Antoniotti, Roberto Moretto, Daniele Rossini, et al.
Cancer Treatment Reviews|July 31, 2021
PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectationsHélène Vanacker, Philipp Harter, Sana Intidhar Labidi-Galy, et al.
Cancer Treatment Reviews|July 31, 2021
Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysisP Trillo Aliaga, F Spada, G Peveri, et al.
Cancer Treatment Reviews|April 16, 2013
Strategies for managing ACTH dependent mineralocorticoid excess induced by abirateroneAnna Pia, Francesca Vignani, Gerhardt Attard, et al.
Cancer Treatment Reviews|April 6, 2013
mTOR inhibitors in advanced breast cancer: ready for prime time?Lesley-Ann Martin, Fabrice André, Mario Campone, et al.
Cancer Treatment Reviews|May 11, 2013
Trastuzumab in small tumours and in elderly womenJoan Albanell, Eva M Ciruelos, Ana Lluch, et al.
Cancer Treatment Reviews|May 21, 2013
Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristicsW Onstenk, J W Gratama, J A Foekens, et al.
Pageof 247